• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Mentice

13.50 SEK+1.50 %13.7, 13.10
Less than 1K followers

MNTC

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.50 %
+7.14 %
+1.50 %
-2.17 %
+1.12 %
-2.37 %
-67.07 %
-84.25 %
-79.78 %

Mentice operates in the medical technology sector. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for use in educational purposes among hospitals and institutes. The largest operations are found in North America and Europe. In addition to the main business, opportunities for leasing, support, and technical service are offered. The headquarters are located in Gothenburg.

Read more
Market cap
379.7M SEK
Turnover
1.07K SEK
Revenue
279.09M
EBIT %
-9.88 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
23.7
2026

Interim report Q2'26

10.11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release10.07.2026, 13.05

Mentice to Present Q2 2026 Interim Report via Webcast

Mentice
Press release09.07.2026, 17.45

DNB Carnegie Access: Mentice: Don’t stop delivering – Q2 preview

Mentice
Regulatory press release01.07.2026, 20.00

Correction: Missing MAR label in earlier Press Release - Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company within Interventional Cardiology

Mentice

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release30.06.2026, 08.05

DNB Carnegie Access: Mentice: Top 20 medtech order further reinforces momentum in MDI

Mentice
Regulatory press release29.06.2026, 18.00

Mentice secures $2.4M in several orders from one Top 20 Global MedTech Company in Interventional Cardiology, focused on Structural Heart Disease

Mentice
Press release01.06.2026, 20.00

Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning

Mentice
Regulatory press release26.05.2026, 22.00

Communique from annual general meeting in Mentice AB

Mentice
Press release08.05.2026, 07.00

DNB Carnegie Access: Mentice: Three consecutive quarters of improvement – Q1 review

Mentice
Press release07.05.2026, 08.30

DNB Carnegie Access: Mentice: Reinforcing the recovery narrative – Q1 initial

Mentice
Regulatory press release07.05.2026, 07.00

INTERIM REPORT JAN–MAR 2026

Mentice
Regulatory press release24.04.2026, 21.15

Annual shareholders’ meeting in Mentice AB

Mentice
Press release23.04.2026, 10.00

Mentice AB Publishes Annual and Sustainability Report for 2025

Mentice
Press release21.04.2026, 09.00

Mentice to Present Q1 2026 Interim Report via Webcast

Mentice
Press release20.04.2026, 18.27

DNB Carnegie Access: Mentice: MDI set to drive continued momentum – Q1 preview

Mentice
Press release23.03.2026, 20.00

Mentice Appoints Rick van Veen as Chief Financial Officer and Announces Changes to the Executive Management Group

Mentice
Press release27.02.2026, 08.19

DNB Carnegie Access: Mentice: Ending 2025 on a high note – Q4 review

Mentice
Regulatory press release26.02.2026, 21.00

Communique from extraordinary shareholders’ meeting in Mentice AB

Mentice
Press release26.02.2026, 08.17

DNB Carnegie Access: Mentice: Firing on all cylinders – Q4 initial take

Mentice
Regulatory press release26.02.2026, 07.00

Mentice publishes the company’s year-end report for the period January–December 2025

Mentice
Press release12.02.2026, 15.00

Mentice to Present the Company's Year-End Q4 Report 2025 via Webcast

Mentice